Reperfusion of Acute Myocardial Infarction in the elderly (clinical characteristics and prognosis) Results of the IMSS Nuevo León infarction code program

Main Article Content

Zapata Ruiz Alejandro
Palacios R Juan Manuel*
De la Cruz O Ramón
Arboine A Luis
Sierra F Ángel
Muñoz Consuegra Carlos

Abstract

Background: The age is an important prognostic factor in patients with acute myocardial infarction. To find no similar data in the Mexican population, it seeks to establish the characteristics and prognosis of older adults carried out mechanical reperfusion treatment.


Methods and results: We carried out a retrospective analysis included a total of 1025 patients in the program code myocardial reperfusion treatment carried out, being the 15.3 % over the age of 75 years. The age range of 33 to 92 years. The mortality rate is increasing exponentially higher age (3.4 % for patients <= 54 years, 6.1% for 55 to 64 years, 9.2% for 65 to 75 years and 15.9 % for the >= 75 years, p<0,001) in patients older than 75 years, primary angioplasty is the preferred method of reperfusion (77.7 %), without finding in this group of patients, an increase in the cerebral vascular event ischemic or hemorrhagic. Over the age of 75 years who develop cardiogenic shock have a much higher mortality compared with the younger (17.6%, 28%, 33% vs 56%, p<0.001).


Conclusions: Despite the different treatments of reperfusion, mortality remains higher in older adults, mainly by multiple comorbidities and a higher rate of ventricular dysfunction.

Downloads

Download data is not yet available.

Article Details

Alejandro, Z. R., Manuel, P. R. J., Ramón, D. la C. O., Luis, A. A., Ángel, S. F., & Carlos, M. C. (2018). Reperfusion of Acute Myocardial Infarction in the elderly (clinical characteristics and prognosis) Results of the IMSS Nuevo León infarction code program. Journal of Cardiovascular Medicine and Cardiology, 5(3), 024–026. https://doi.org/10.17352/2455-2976.000066
Research Article(s)

Copyright (c) 2018 Alejandro ZR, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Shanmugam VB, Harper R (2015) An overview of PCI in the very elderly. J Geriatr Cardiol. 12: 174−184. Link: https://goo.gl/cJUkNT

Wang TY, Gutiérrez A, Peterson DE (2011) Percutaneous coronary intervention in the elderly Nat. Rev. Cardiol. 8:79–90. Link: https://goo.gl/SEHBkB

Ibanez B, James S, Agewall S (2017) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal.1–66. Link: https://goo.gl/rPW6PT

Levine GN, Bates ER (2011) ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention J Am Coll Cardiol. 58:44–122. Link: https://goo.gl/bhooEM

Campo C, Ferreira RP, Teixeira C (2013) Percutaneous Coronary Intervention using Transradial Access in Elderly vs. Non-Elderly Patients Rev Bras Cardiol Invasiva. 21:36-42. Link: https://goo.gl/WVS5WY

Thiemann DR, Coresh F, Shulman P (2000) Lack of Benefit for Intravenous Thrombolysis in Patients with Myocardial Infarction Who Are Older Than 75 Years. Circulation. 101:2239-2246. Link: https://goo.gl/1ghfmb

Capodanno D, Angiolillo DJ (2010) Antithrombotic Therapy in the Elderly. J Am Coll Cardiol. 56: 1683–92. Link: https://goo.gl/UKf99y

Hsieh V, Jolly SS (2012) Should Radial Access Be the Preferred Approach in the Elderly? Rev Bras Cardiol Invasiva; 20. Link: https://goo.gl/APTMY2

Sim WL, Mutha V (2017) Clinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population. World J Cardiol. 9: 437-441. Link: https://goo.gl/nRttFz

Guagliumi G, Stone GW, Cox DA (2004) Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction, Results From the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial Circulation.110:1598-1604. Link: https://goo.gl/sVs5Fc